GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » Median PS Value

Fresenius Medical Care AG (Fresenius Medical Care AG) Median PS Value

: $45.31 (As of Today)
View and export this data going back to 1996. Start your Free Trial

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Fresenius Medical Care AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $35.738. Fresenius Medical Care AG's 10-Year median PS Ratio is 1.2678. Therefore, the Median PS Value for today is $45.31.

As of today (2024-04-16), Fresenius Medical Care AG's share price is $18.60. Fresenius Medical Care AG's Median PS Value is $45.31. Therefore, Fresenius Medical Care AG's Price to Median PS Value for today is 0.41.

The historical rank and industry rank for Fresenius Medical Care AG's Median PS Value or its related term are showing as below:

FMS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.33   Med: 0.76   Max: 1.01
Current: 0.41

During the past 13 years, the highest Price to Median PS Value of Fresenius Medical Care AG was 1.01. The lowest was 0.33. And the median was 0.76.

FMS's Price-to-Median-PS-Value is ranked better than
83.12% of 231 companies
in the Healthcare Providers & Services industry
Industry Median: 0.74 vs FMS: 0.41

Fresenius Medical Care AG Median PS Value Historical Data

The historical data trend for Fresenius Medical Care AG's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.61 55.00 49.37 49.57 46.89

Fresenius Medical Care AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.57 50.36 50.23 46.97 46.89

Competitive Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Price-to-Median-PS-Value Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Price-to-Median-PS-Value falls into.



Fresenius Medical Care AG Median PS Value Calculation

Fresenius Medical Care AG's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=35.738*1.2678
=45.31

10-Year Median PS Ratio is 1.2678.
Fresenius Medical Care AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.738.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius Medical Care AG  (NYSE:FMS) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Fresenius Medical Care AG's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=18.60/45.31
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius Medical Care AG Median PS Value Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Executives
Helen Pring Giza Board of Directors

Fresenius Medical Care AG (Fresenius Medical Care AG) Headlines